KGLOW [GHK-CU (50mg) / BPC-157 (10mg) / TB500 (10mg) / KPV (10mg)]

About this formulation

KLOW expands on the GLOW formulation by adding KPV. The four-peptide blend combines:

• GHK-Cu (50mg) — copper-binding tripeptide investigated for collagen synthesis
• BPC-157 (10mg) — gastric juice-derived peptide investigated for angiogenesis and inflammation modulation
• TB-500 (10mg) — Thymosin Beta-4 fragment investigated for cell migration
• KPV (10mg) — tripeptide fragment of α-MSH investigated for anti-inflammatory and antimicrobial activity

Mechanism in Research Literature

The four peptides operate through distinct mechanisms:

• GHK-Cu: copper delivery, collagen synthesis stimulation, gene expression modulation
• BPC-157: angiogenesis, GH-receptor expression, inflammatory cytokine modulation
• TB-500: actin regulation, cellular migration
• KPV: melanocortin receptor activation, NF-kB inhibition, antimicrobial activity
• Combined: literature describes overlapping but complementary coverage of repair (BPC-157, TB-500), collagen synthesis (GHK-Cu), and inflammation control (KPV)

Research Context

The component peptides appear together in literature exploring:

• Tissue repair with inflammatory components
• Dermal regeneration
• Gut and mucosal repair research
• Wound healing with bacterial co-infection models

Related Research Peptides

KLOW sits alongside the related GLOW 50 formulation (which omits KPV) and the standalone GHK-Cu, BPC-157, TB-500, and KPV product pages.

For research use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.